Index
1 Poliovirus Vaccine Market Overview
1.1 Product Overview and Scope of Poliovirus Vaccine
1.2 Poliovirus Vaccine Segment by Type
1.2.1 Global Poliovirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Poliovirus Vaccine Segment by Application
1.3.1 Global Poliovirus Vaccine Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliovirus Vaccine Revenue 2019-2030
1.4.2 Global Poliovirus Vaccine Sales 2019-2030
1.4.3 Global Poliovirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliovirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poliovirus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
2.7 Poliovirus Vaccine Market Competitive Situation and Trends
2.7.1 Poliovirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliovirus Vaccine Players Market Share by Revenue
2.7.3 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliovirus Vaccine Retrospective Market Scenario by Region
3.1 Global Poliovirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliovirus Vaccine Global Poliovirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Poliovirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Poliovirus Vaccine Sales by Region: 2025-2030
3.3 Global Poliovirus Vaccine Global Poliovirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poliovirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poliovirus Vaccine Revenue by Region: 2025-2030
3.4 North America Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliovirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Poliovirus Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliovirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poliovirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliovirus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliovirus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliovirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poliovirus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliovirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliovirus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poliovirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Poliovirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Poliovirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poliovirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poliovirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poliovirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poliovirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliovirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Poliovirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Poliovirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poliovirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poliovirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poliovirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poliovirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Poliovirus Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Poliovirus Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliovirus Vaccine Industry Chain Analysis
7.2 Poliovirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliovirus Vaccine Production Mode & Process
7.4 Poliovirus Vaccine Sales and Marketing
7.4.1 Poliovirus Vaccine Sales Channels
7.4.2 Poliovirus Vaccine Distributors
7.5 Poliovirus Vaccine Customers
8 Poliovirus Vaccine Market Dynamics
8.1 Poliovirus Vaccine Industry Trends
8.2 Poliovirus Vaccine Market Drivers
8.3 Poliovirus Vaccine Market Challenges
8.4 Poliovirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer